Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Additional Information (Details)

v3.22.4
Stockholders' Equity - Additional Information (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 9 Months Ended
Aug. 03, 2022
Aug. 01, 2022
Aug. 13, 2021
May 31, 2022
Jan. 31, 2022
Feb. 28, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Subsidiary or Equity Method Investee [Line Items]                            
Common stock, shares authorized   70,000,000         70,000,000         70,000,000   30,000,000
Preferred stock, shares authorized   30,000,000         30,000,000         30,000,000   70,000,000
Common stock, par value             $ 0.0001         $ 0.0001   $ 0.0001
Preferred stock, shares issued             0         0   0
Preferred stock, par value             $ 0.0001         $ 0.0001   $ 0.0001
Common stock, shares issued             10,945,904         10,945,904   7,584,980
Number of common stock sold       11,111   263,729                
Sale of common stock, price per share       $ 9   $ 9                
Common stock per share           $ 9.00                
Gross proceeds from sale of common stock $ 9,100,000     $ 99,999   $ 2,373,561           $ 2,473,560 $ 5,366,170  
Warrants exercise price, per share   $ 6.25                        
Transaction costs       $ 0   $ 0                
Stock compensation expense             $ 532,438     $ 778,544   1,830,536 2,108,868  
Deemed dividend on warrant modification                       $ (450,578)    
Warrants exercised, shares       394,501                    
Cashless exercise at fair market value per share       $ 9                    
Issuance of common shares upon cashless exercise of warrants, shares       315,601                    
Stock options outstanding             6,511,910         6,511,910   5,797,185
Fair value assumptions, contractual term                       7 years    
Exercise price percentage                       110.00%    
Percentage of shares granted                       10.00%    
Warrants and rights exercisable period   Jan. 23, 2023                        
Class of warrant or right date from which warrants or rights expire   Jul. 27, 2027                        
Warrants             $ 215,705         $ 215,705    
Gain on remeasurement of warrant liability             $ (128,030)     $ 100,780   $ (128,030) $ 1,546,280  
Black-Sholes Method                            
Subsidiary or Equity Method Investee [Line Items]                            
Risk free interest rate 2.82%                          
Volatility rate 77.50%                          
Fair value assumptions, contractual term 5 years                          
Warrants $ 343,735                          
January 1 to January 26, 2022 [Member]                            
Subsidiary or Equity Method Investee [Line Items]                            
Common stock, par value             $ 8.87         $ 8.87    
January 27 to May 31, 2022 [Member]                            
Subsidiary or Equity Method Investee [Line Items]                            
Sale of common stock, price per share             9         9    
June 1, 2022 to August 1, 2022 [Member]                            
Subsidiary or Equity Method Investee [Line Items]                            
Sale of common stock, price per share             $ 5         $ 5    
January 1, 2021 to February 28, 2021 [Member]                            
Subsidiary or Equity Method Investee [Line Items]                            
Sale of common stock, price per share                   $ 1.80     $ 1.80  
March 1, 2021 to June 6, 2021 [Member]                            
Subsidiary or Equity Method Investee [Line Items]                            
Sale of common stock, price per share                   $ 1.83     $ 1.83  
Maximum                            
Subsidiary or Equity Method Investee [Line Items]                            
Fair value assumptions, contractual term                       10 years    
Warrants to purchase aggregate of common stock   100,000                        
2018 Stock Option Plan                            
Subsidiary or Equity Method Investee [Line Items]                            
Common stock reserved for issuance             0         0    
Stock options outstanding             1,924,500         1,924,500    
Amended and Restated 2020 Equity Incentive Plan                            
Subsidiary or Equity Method Investee [Line Items]                            
Common stock reserved for issuance             0         0    
Stock options outstanding             3,993,023         3,993,023    
2021 Equity Incentive Plan                            
Subsidiary or Equity Method Investee [Line Items]                            
Common stock reserved for issuance   1,909,518         1,315,131         1,315,131    
Stock options outstanding             594,387         594,387    
IPO                            
Subsidiary or Equity Method Investee [Line Items]                            
Common stock, shares issued   219,872                        
Number of common stock sold   2,000,000                        
Sale of common stock, price per share   $ 5                        
Issuance of common shares, value   $ 1,099,360         $ 8,750,095              
Common stock per share   $ 5.00       $ 5.00                
Gross proceeds from common stock   $ 10,000,000                        
Number of warrants exercise   20,520                        
Warrants exercise price, per share   $ 5.00                        
Overallotment Option                            
Subsidiary or Equity Method Investee [Line Items]                            
Number of common stock sold 300,000                          
Sale of common stock, price per share $ 5                          
Common stock per share $ 5.00                          
Gross proceeds from common stock $ 1,500,000                          
Overallotment Option | Maximum                            
Subsidiary or Equity Method Investee [Line Items]                            
Class of warrant or right additional purchase aggregate of common stock 15,000                          
Common Stock                            
Subsidiary or Equity Method Investee [Line Items]                            
Number of common stock sold       11,111   263,729                
Sale of common stock, price per share       $ 9   $ 9.00                
Issuance of restricted common shares, Shares                     15,278      
Issuance of common shares upon exercise of warrants, Shares       153,000 61,111     468,601 61,111          
Proceeds from issuance of common stock upon exercise of warrants       $ 275,400 $ 110,000                  
Common Stock | IPO                            
Subsidiary or Equity Method Investee [Line Items]                            
Number of common stock sold             2,300,000              
Issuance of common shares, value             $ 230              
Founder                            
Subsidiary or Equity Method Investee [Line Items]                            
Stock compensation expense                         $ 202,500  
Issuance of restricted common shares, Shares                         87,500  
Restricted Stock Awards                            
Subsidiary or Equity Method Investee [Line Items]                            
Founders shares vested                       58,333    
Unvested shares             0         0   58,333
Restricted Stock Awards | Founder                            
Subsidiary or Equity Method Investee [Line Items]                            
Shares granted                         112,500  
MAIA Stock Warrants                            
Subsidiary or Equity Method Investee [Line Items]                            
Warrant modification, value         $ 144,497                  
Deemed dividend on warrant modification                 $ 450,578          
Stock Options                            
Subsidiary or Equity Method Investee [Line Items]                            
Weighted-average grant date fair value                       $ 3.11 $ 2.57  
Unrecognized compensation             $ 3,829,045         $ 3,829,045    
Unrecognized compensation expense, recognized period                       3 years 4 months 24 days    
Stock Options | Maximum                            
Subsidiary or Equity Method Investee [Line Items]                            
Fair value assumptions, contractual term                       6 years 3 months 6 years 6 months  
Stock Options | Minimum                            
Subsidiary or Equity Method Investee [Line Items]                            
Fair value assumptions, contractual term                       5 years 5 years  
T H I O | Founder                            
Subsidiary or Equity Method Investee [Line Items]                            
Issuance of restricted common shares, Shares     612,500                      
T H I O | Restricted Stock Awards | Founder                            
Subsidiary or Equity Method Investee [Line Items]                            
Founders shares vested     612,500                      
Founders shares canceled     612,500